Delivery Order SPE2DB22D1106-SPE2DB24FFLR3
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$28K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award for $11,013.52 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,198,277 units of Ondansetron HCL 4 mg tablets. The contract is a Firm Fixed Price Delivery Order that will run through February 7, 2025. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this award, which does not have a set-aside designation. The company also holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,250 units of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $2,644.93 and is structured as a Delivery Order with a Firm Fixed Price pricing type. The contract does not have a set-aside designation and has an ultimate completion date of July 26, 2024. Amerisourcebergen, through its Corporate Office...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,354,677 units of Ondansetron HCL 8 mg tablets in 30-count packages. The award, valued at $1,508.38, is a Firm Fixed Price delivery order contract with an ultimate completion date of August 6, 2024. It is not designated as a set-aside contract. Amerisourcebergen, through its Corporate Office division, has...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,573,144 units of Ondansetron HCL 4 mg tablets. The $4,383.54 firm fixed-price contract has an ultimate completion date of December 2, 2024. This award is a delivery order placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This contract award, valued at $2,615.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,696,337 units of Ondansetron HCL 4 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,568,236,169 units of the pharmaceutical drug Ondansetron HCL 4 mg Tablet. The contract has a ceiling value of $12,635.26 and a period of performance through May 14, 2025. AmerisourceBergen Drug Corp is the prime contractor, with no set-aside designation indicated. This contract appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) vehicle worth up...
This federal contract award, valued at $4,555.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of 4,566,148,838 units of Ondansetron HCL 4 mg Tablets in 30-count packages. The award has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $40,558.87, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office division. The contract is for the delivery of 4,565,504,798 units of Ondansetron ODT 4 mg tablets in 30-count packages. This is a firm-fixed-price delivery order contract with an ultimate completion date of August 20, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract without any...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,172.82, is for the delivery of 4,564,881,274 units of Ondansetron HCL 4 mg tablets. The contract has a completion date of June 12, 2024 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,310 units of Ondansetron hydrochloride 8 mg tablets. The contract has a firm fixed price of $17,144.53 and a completion date of August 1, 2024. The award is not designated as a set-aside contract. Amerisourcebergen's Corporate Office division is responsible for fulfilling this delivery order, which is part of a larger...